Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BIOD-123
BIOD-123
Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
Seeking Alpha
Thu, 09/12/13 - 11:39 am
Biodel
insulin
diabetes
BIOD-123
Biodel's BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog(R)
Yahoo
Mon, 09/9/13 - 09:52 am
Biodel
BIOD-123
clinical trials
diabetes
type 1 diabetes
Is This a MannKind Killer?
Motley Fool
Tue, 09/3/13 - 09:54 am
MannKind
diabetes
Afrezza
BIOD-123
insulin
Biodel
Why Biodel Will Have Positive Phase II Results
Seeking Alpha
Wed, 07/31/13 - 09:20 am
Biodel
BIOD-123
type 1 diabetes
type 2 diabetes
diabetes
3 Biotech Catalysts Primed To Be Successful In Q3
Seeking Alpha
Wed, 07/24/13 - 09:48 am
BIOD-123
Biodel
MannKind
Afrezza
GTx
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
Thu, 05/30/13 - 09:01 am
insulin
diabetes
Biodel
BIOD-123
MannKind
Afrezza
Biodel: Reemerging From Obscurity In 2013
Seeking Alpha
Thu, 04/11/13 - 11:34 am
Biodel
Eli Lilly
BIOD-123
recombinant human insulin
BIOD-250